These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2006-001984-53 Effectiveness of Dalteparin Therapy as Intervention in recurrent pregnancy loss 2013-05-06 due-trials
Not reported 2006-006957-29 Influence of Duloxetin on C-fiber function and perception of deep somatic pain in major depression 2009-09-03 due-trials
Not reported 2006-006984-21 prospective, randomized, open, multicentre trial to assess the influence of empiric antibiotic monotherapy with meropenem (Meronem) versus combination with moxifloxacin (Avalox) on the organ function ... 2011-11-30 due-trials
Reported results 2007-001548-36 Nasale Inhalation von Pulmozyme bei Patienten mit Mukoviszidose und chronischer Rhinosinusitis mit dem Pari Sinus-Vernebler. - bizentrische, randomisierte, doppel-blinde, placebo-kontrollierte, prosp... 2009-02-12 due-trials
Not reported 2007-004333-42 Prospective randomized clinical multicenter trial about the effect of an adjunctive intravenous treatment with sodium selenite (selenase®T, double-blind) and a procalcitonin guided causal therapy (ope... 2014-11-30 due-trials
Completed, but no date, and reported results Terminated 2008-000164-17 Nasale Inhalation von Tobramycin mit dem Pari Sinus-Vernebler bei Patienten mit Mukoviszidose und Pseudomonasnachweis im Nasen-Nasennebenhöhlenbereich. Nasal inhalation of tobramycin by the Pari Sin... bad-data
Reported results 2008-007877-19 Nasale Inhalation von Colistin mit dem Pari-Sinus-Vernebler bei Patienten mit Mukoviszidose und Pseudomonasnachweis im Nasen-Nasennebenhöhlenbereich. Nasal inhalation of colistin by the Pari Sinus ne... 2012-04-19 due-trials
Exempt 2009-011902-41 Split-dose TPF-Induction chemotherapy before Surgery of Oropharyngeal and cavity of the mouth Cancer 2016-01-13 not-yet-due
Ongoing 2010-019688-12 Prospective placebo controlled trial: Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris during percutaneous coronary interventions under an adjuncti... not-yet-due
Not reported Terminated 2010-022660-12 A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation 2014-12-11 due-trials
Listed as ongoing, but also has a completion date 2010-024262-22 Treatment optimization of newly diagnosed Ph/BCR-ABL positive patients with chronic myeloid leukemia (CML) in chronic phase with nilotinib vs. nilotinib plus interferon alpha induction and nilotinib o... 2022-05-31 bad-data
Completed, but no date Terminated 2012-003023-38 Phase II study of Bortezomib, Melphalan, Prednisone (VMP) followed by Lenalidomide maintenance vs. VMP without maintenance in Myeloma patients not eligible to high-dose chemotherapy and autologous ste... bad-data
Ongoing 2014-004013-85 Sequential versus simultaneous vaccination with pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPV23) in unvaccinated older adults: Immunological memory and antibody l... not-yet-due
Ongoing 2015-003502-16 Treatment optimization for patients with chronic myeloid leukemia (CML) with treatment naïve disease (1st line) and patients with resistance or intolerance against alternative Abl-Kinase Inhibitors (≥... not-yet-due
Reported results 2016-000136-17 Prospective, randomized, multicenter clinical trial on the impact of Therapeutic Drug Monitoring (TDM) of piperacillin on organ functions and survival in the treatment of severe sepsis or septic shock... 2020-01-06 due-trials
Reported results Terminated 2016-002388-33 Therapeutic drug monitoring (TDM) for personalized antibiotic treatment with piperacillin-tazobactam (PipTaz) in patients with febrile neutropenia after myelo-suppressive cytostatic chemotherapy T... 2018-06-10 due-trials
Completed, report not yet due 2016-004396-51 Pentaerithrityl tetranitrate (PETN) for secondary prevention of intrauterine growth restriction (PETN Trial) Pentaeritrithyltetranitrat (PETN) zur Sekundärprophylaxe der intrauterinen Wachstumsret... 2021-11-29 not-yet-due
Completed, but no date Terminated 2018-001874-89 Randomised controlled multicentre study of albumin replacement therapy in septic shock Randomisierte kontrollierte multizentrische Studie zur Albuminersatztherapie im septischen Schock bad-data
Ongoing 2018-002256-33 Frontline Asciminib combination in chronic phase CML not-yet-due
Not reported 2018-003692-35 Effects of empagliflozin on diuresis and renal function in patients with acute decompensated heart failure Auswirkungen von Empagliflozin auf Diurese und Nierenfunktion bei Patienten mit akuter dek... 2021-06-29 due-trials
Completed, but no date Terminated 2019-000136-26 Midostaurin in MRD positive acute myeloid leukemia after allogeneic stem cell transplantation bad-data
Completed, report not yet due 2019-001324-35 Randomized single-blind study on the adherence to treatment with topical methylprednisolone aceponate (Advantan®) in different vehicles (AD-HERE) 2022-07-19 not-yet-due
Not reported 2020-001481-11 Front line treatment with Ruxolitinib in stage II/III Covid-19 patients with defined Hyperinflammation 2021-06-30 due-trials
Ongoing 2021-002098-25 A randomized, controlled, multicenter, open label phase II clinical study to evaluate infliximab in the treatment of patients with severe COVID-19 disease (INFLIXCOVID) Eine randomisierte, kontro... not-yet-due
Ongoing 2021-002300-12 Epirubicin for the Treatment of Sepsis & Septic Shock Epirubicin für die Behandlung von Sepsis und septischen Schock not-yet-due